Hello Al,
based on theoretical analysis (and first experiences -if available), which Covid vaccine technology would you prefer for GBM patients? One with mRNA technology (Moderna, Biontech) or modified adenoviruses as a carrier virus (AstraZeneca) ?
I’ve read somewhere that mRNA modified viruses tend to home to tumors..and therefore, theoretically, they wouldn’t produce sufficient COvid protection, but on the other hand, it is possible that the mRNA vaccine makes GBM immunologically speaking „hot“ and produce an immune response?
Thanks,
Harvey
based on theoretical analysis (and first experiences -if available), which Covid vaccine technology would you prefer for GBM patients? One with mRNA technology (Moderna, Biontech) or modified adenoviruses as a carrier virus (AstraZeneca) ?
I’ve read somewhere that mRNA modified viruses tend to home to tumors..and therefore, theoretically, they wouldn’t produce sufficient COvid protection, but on the other hand, it is possible that the mRNA vaccine makes GBM immunologically speaking „hot“ and produce an immune response?
Thanks,
Harvey
Comment